(Q36691795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

review article

1 reference

title

Predicting risk of breast cancer recurrence using gene-expression profiling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Michail Ignatiadis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

101-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

Molecular portraits of human breast tumours

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

BRAF mutation predicts sensitivity to MEK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Adjuvant docetaxel for node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.1.101

21 January 2018

Identifiers

DOI

10.2217/14622416.8.1.101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17187513%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference